Atjaunināt sīkdatņu piekrišanu

Nuclear Signaling Pathways and Targeting Transcription in Cancer Softcover reprint of the original 1st ed. 2014 [Mīkstie vāki]

Edited by
  • Formāts: Paperback / softback, 439 pages, height x width: 235x155 mm, weight: 6788 g, XII, 439 p., 1 Paperback / softback
  • Sērija : Cancer Drug Discovery and Development
  • Izdošanas datums: 23-Aug-2015
  • Izdevniecība: Humana Press Inc.
  • ISBN-10: 1493901125
  • ISBN-13: 9781493901128
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 136,16 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Standarta cena: 160,19 €
  • Ietaupiet 15%
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Paperback / softback, 439 pages, height x width: 235x155 mm, weight: 6788 g, XII, 439 p., 1 Paperback / softback
  • Sērija : Cancer Drug Discovery and Development
  • Izdošanas datums: 23-Aug-2015
  • Izdevniecība: Humana Press Inc.
  • ISBN-10: 1493901125
  • ISBN-13: 9781493901128
Citas grāmatas par šo tēmu:
This book summarizes the roles, significance, and potential therapeutic targeting of transcriptional factors (TFs) from the perspective of signaling cascade. It details the physiologic and pathologic roles of TFs in specific representative organ systems.

At the moment, there is no dedicated book to summarize the roles, the significance, and potential therapeutic targeting of transcriptional factors from the perspective of signaling cascade, and thus, directly impacting the functionality of transcriptional factors in cancer. In addition, this book will offer a comprehensive basic and clinical science behind the functions of representative core transcriptional factors. These chapters will serve as a treasure for all those who have an interest in the basis, progression, and targeting of human cancer. Each chapter will be intended to provide comprehensive, up-to-date information by the leaders about the physiologic and pathologic roles of TFs in specific representative organ systems of prime importance. The book will consist of chapters that will give biomedical students, under and graduate students, basic sciences and clinical cancer fellows, residents and researchers, and oncology educators will get a thorough summary of the overall subject. The readers will be able to understand the important current information and views on specific TFs and its role in cancer in areas outside their own expertise or experience. A special emphasis will be also placed on the "classic" papers as well as perspectives on future directions for the field.
Preface.- Steroid Receptor Coactivators (SRCs) as Integrators of
Multiple Signaling Pathways in Cancer Progression.- Role of
Alteration/Deficiency in Activation (ADA) Complex in the Cell Cycle, Genomic
Instability and Cancer.- RUNX2 Transcriptional Regulation in Development and
Disease.- Epigenetic Mechanisms of Cancer Metastasis.- Regulatory Effects of
Arsenic on Cellular Signaling Pathways: Biological Effects and Therapeutic
Implications.- Nuclear Factors Linking Cancer and Inflammation.- Regulation
of the Jak/STATs Pathways by Histone Deacetylases.- Receptor Tyrosine Kinases
in the Nucleus: Nuclear Functions and Therapeutic Implications in Cancers.-
Nucleolar Signaling Determines Cell Fate The RP-Mdm2-p53 Axis Fine-Tunes
Cellular Homeostasis.- Transcriptional Regulation of Lipogenesis as a
Therapeutic Target for Cancer Treatment.- Selective Inhibition of
Acetyl-Lysine Effector Domains of the Bromodomain Family in Oncology.- Domain
Specific Targeting of Cancer.- The Potential of Targeting Splicing for Cancer
Therapy.- Exploiting Cell Cycle Pathways in Cancer Therapy: New (and Old)
Targets and Potential Strategies.- Histone Demethylases in Prostate Cancer.-
Therapeutic Significance of Chromatin Remodeling Complexes in Cancer.- Index.